Webinar: Gene-Modified Cell Therapy: From Vector Design to cGMP Manufacturing

Enabling Continuity Across the Gene-Modified Cell Therapy Journey

As gene-modified cell therapy programs advance toward commercialization, maintaining continuity across vector design, critical materials, and manufacturing becomes increasingly important.

This on-demand joint webinar with Minaris, Bridging Vector Design, Critical Materials, and cGMP Manufacturing: Enabling Continuity Across the Gene-Modified Cell Therapy Journey**,** explores how connecting these elements early can improve consistency and support a more scalable path from development to commercialization.

Watch the webinar to discover ways to:

• Reduce downstream risk through upstream planning
• Improve reproducibility across development and manufacturing
• Support scalable cGMP manufacturing strategies
• Enable smoother progression toward commercialization

Watch on demand now to learn how integrated planning reduces risk and supports scalability.